Clinical trial

Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed by Unrelated…

NCT00093743 · Fred Hutchinson Cancer Center, Other · Completed

Key facts

NCT number NCT00093743
Title Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed by Unrelated Donor Stem Cell Transplant in Treating Patients With Fanconi Anemia
Official title Low-Dose Total Body Irradiation and Fludarabine Followed By Unrelated Donor Stem Cell Transplantation for Patients With Fanconi Anemia - A Multicenter Trial
Lead sponsor Fred Hutchinson Cancer Center, Other
Collaborators National Heart, Lung, and Blood Institute (NHLBI) NIH National Cancer Institute (NCI)
Status Completed
Phase Phase 1
Study type Interventional
Conditions Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13, q22), Adult Acute Myeloid Leukemia With t(15, 17)(q22, q12), Adult Acute Myeloid Leukemia With t(16, 16)(p13 and 6 more
Intervention type Drug, Procedure, Radiation
Interventions fludarabine phosphate, cyclosporine, total-body irradiation, allogeneic bone marrow transplantation, allogeneic hematopoietic stem cell transplantation, peripheral blood stem cell transplantation, mycophenolate mofetil
Enrollment 2
Start date Jan 1, 2000
Primary completion Sep 1, 2007
First posted Oct 8, 2004
Last update posted Feb 20, 2017
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies